Publishing Negative Results to Optimize the Biopharmaceutical Innovation
نویسندگان
چکیده
منابع مشابه
The Importance of Publishing Negative Results
1. Scientific thinking is not always open minded and without bias; accepted theories can be hard to overthrow—and I am referring here to scientists, not the general public. Publishing only selective information, i.e. positive results, does not allow one to visualize/understand the whole of the situation. However, by publishing negative data or results that contradict the establish way of thinki...
متن کاملBiopharmaceutical Innovation System and the Influence of Policies: The Case of Taiwan (2000-2008)
This article discusses the influence of policies on the development of biopharmaceuticals. We choose the experiences of Taiwan for our empirical study and focus on the evolution between 2000 and 2008; in the period of time the country provides an interesting example for further exploration of biopharmaceutical policies. Among all the policies, the two National Programs (National Research Progra...
متن کاملDual Spacization Approach to the Electronic Publishing
Dual spacization of publishing means emergence of digital publishing in online and offline virtual environments along with analogue publishing. Analogue publishing is a kind of publishing that is produced in the form of physical printed writings as they appear in a single paper, single or many pages newspapers and magazines and books, writings on leaves and pieces of trees, natural skin and lea...
متن کاملCrystallization data mining in structural genomics: using positive and negative results to optimize protein crystallization screens.
Recent efforts to collect and mine crystallization data from structural genomics (SG) consortia have led to the identification of minimal screens and novel screening strategies that can be used to streamline the crystallization process. Two groups, the Joint Center for Structural Genomics and the University of Toronto, carried out large-scale crystallization trials on different sets of bacteria...
متن کاملBiopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s)
Background: This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS).Methods: Two data sources including archival documentary data and field interviews were used in this study. Archival documentary data was collected from China Food and Drug Administration (CFDA) and Chinese National Knowled...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: MOJ Cell Science & Report
سال: 2017
ISSN: 2374-6912
DOI: 10.15406/mojcsr.2017.04.00095